NGI Sweden Order Portal
This portal is for submitting orders for services provided by the National Genomics Infrastructure Sweden (NGI). To make an order, please log in and choose the application most suitable for your project. If uncertain about the choice of technology, please select the “Request a meeting” option. You can read more about the different technologies and How to place an order under "Information" in the menu at the top of the page.
Projects from other countries are admissible, but have lower priority than projects performed by researchers based in Sweden. Depending on the queue situation, NGI may decide to decline a non-Swedish project altogether.
Turn Around Times and Status for the Stockholm node.
If you are unsure about the appropriate method for your scientific problem, request a meeting for a discussion with us.
Order form for Illumina sequencing.
Order form for sequencing by Ion Proton or Ion S5XL.
Order form for PacBio sequencing. This is available only at the NGI Uppsala UGC node.
Order form for genotyping and DNA methylation analysis using the Illumina EPIC beadchip.
|
We're hiring!
(2019-03-19)
We are looking for a research engineer for our production team to work with library preparations and quality controls. We are looking for someone who is very careful and responsible and thrives on daily handling and preparation of important samples in a quality-assured laboratory environment to promote research throughout Sweden. The samples are varied and the methods advanced, so some problem solving is a natural part of the work. Read more about the job here. |
|
NGI and NBIS provide drop in consultation meetings for those preparing VR applications
(2019-03-05)
Welcome to a free drop-in session to discuss your plans and study design with us at your local university before submitting your VR application! Meet our bioinformatics experts and sequencing coordinators to discuss new technology updates, input on your study design, opportunities for bioinformatics support, and guidance on the new data management plans. Find schedule and more information here. |
|
Season's greetings from NGI!
(2018-12-21)
In the upcoming months NGI is planning to phase out both the HiSeq 2500 and HiSeq X instruments and moving all sequencing to the NovaSeq platform. This means there will be some changes in our pricing and order model and we will keep you updated. Meanwhile, if you have any questions of how this will affect your research don’t hesitate to get in contact with us at support@ngisweden.se We are looking forward to an exciting new year and wishing you all a happy holidays! |
|
Christmas holiday 2018
(2018-12-08)
NGI Portal NGI Stockholm NGI Uppsala - SNP&SEQ (Illumina) NGI Uppsala - UGC (PacBio/IonTorrent/Sanger) |
|
The New NovaSeq 6000: Costs, indexing and strategies
(2018-09-17)
Date: September 25th, 9-11 in Gamma 2 lunchroom, SciLifeLab Solna. Talks from IDT, Illumina, and SciLifeLab staff. Coffee and breakfast provided. Topics include: Pricing updates at NGI, project pooling policies, choosing indexes for large flow cells, and avoiding index hopping. You will also have the chance to talk to representatives from IDT and Illumina, as well as meeting our project coordinators to plan your upcoming projects. |
|
BiG Talks – Bioinformatics and Genomics Seminar Series
(2018-05-31)
Date: June 11, 10.30-11.30 in Trippelrummet, Navet, SciLifeLab Uppsala and online Title: Genome sequencing of 15,000 healthy elderly Australians: implications for clinical genetics Speaker: Dr. Paul Lacaze, Head of the Public Health Genomics Program, Monash University, Melbourne Australia The ASPREE Healthy Ageing Biobank contains ~15,000 consented samples from individuals aged 70 years or older participating in the ASPirin in Reducing Events in the Elderly (ASPREE) study – Australia’s largest clinical trial and longitudinal study of healthy ageing. All ASPREE biobank samples are being sequenced using a targeted ‘super-panel’ of 750 genes used commonly in clinical testing, Over 11,500 samples have been sequenced (May 2018), identifying hundreds of actionable pathogenic variants in individuals lacking any apparent signs and symptoms of genetic disease beyond 70 years. Results will be presented on these findings, with implications for our understanding of penetrance and clinical actionability for genes used in routine testing. BiG Talks – Bioinformatics and Genomics seminar series arranged in collaboration with SciLifeLab platforms NBIS, NGI and CG For more information and to register, please visit the SciLifeLab website. |
NGI Sweden is hosted by Science for Life Laboratory (SciLifeLab). See the NGI pages at the SciLifeLab web site for more information.
NGI includes facilities established by profs Ulf Gyllensten (Uppsala), Ann-Christine Syvänen (Uppsala) and Joakim Lundeberg (Stockholm). The National Genomics Infrastructure (NGI) was launched January 1st 2013. It originates from the VR RFI infrastructure SNISS.
NGI is supported by SciLifeLab, the Swedish Research Council (Vetenskapsrådet, VR) and host universities (KI, KTH, SU, UU). In addition, the Knut and Alice Wallenberg Foundation (KAW) has provided funding for instruments and computational infrastructure.
|
|
|
|
|
|
|
|